H Kamiya1,2, Payam Akhyari3, J-P Minol1, A C Ites1, T Weinreich1, S Sixt4, P Rellecke4, U Boeken1, A Albert1, A Lichtenberg1. 1. Department of Cardiovascular Surgery, Medical Faculty, Heinrich Heine University Duesseldorf, Moorenstrasse 5, 40225, Duesseldorf, Germany. 2. Department of Cardiac Surgery, Asahikawa Medical University, 2-1-1-1, Midorigaoka Higashi, Asahikawa, 078-8510, Japan. 3. Department of Cardiovascular Surgery, Medical Faculty, Heinrich Heine University Duesseldorf, Moorenstrasse 5, 40225, Duesseldorf, Germany. payam.akhyari@med.uni-duesseldorf.de. 4. Department of Anesthesiology, Medical Faculty, Heinrich Heine University Duesseldorf, Moorenstrasse 5, 40225, Duesseldorf, Germany.
Abstract
OBJECTIVE: Current techniques for mitral valve repair (MVR) in Barlow's disease require high level of surgical expertise due to a complex anatomy. A novel and simple standardized technique that particularly considers the pathological changes of the mitral valve in Barlow's disease has been developed. METHODS: Between 2009 and 2013, 22 patients underwent minimally invasive MVR for Barlow's disease and severe mitral regurgitation (MR). A simple, standardized technique was applied, including resection of P2 segment of posterior mitral leaflet (PML) with preservation of the shortest chordae, transfer of the preserved chordae to A2, and implantation of a semi-rigid open ring. In 2015, all patients were contacted for follow-up by transthoracic echocardiography (TTE) and interviewed for their clinical status. RESULTS: During follow-up (mean 2.8 ± 1.1 years; 100% complete), one patient died due to abdominal bleeding 4 months after the initial MVR and one patient with severe calcification of PML underwent valve replacement due to recurrence of MR. Among the remaining cohort (mean follow-up 3.0 ± 1.0 years), NYHA class I, II and III was present in 13, 6, and 1, respectively. TTE demonstrated MR grade 0, 1+, or 2+ in 40, 55, and 5%, respectively, with mean and maximum transvalvular gradients ranging at 1.9 ± 1.7 and 4.7 ± 3.3 mmHg, respectively. CONCLUSIONS: A simple and standardized technique facilitates the repair of MR in the presence of Barlow's, simultaneously addressing the height of PML and the position of the anterior leaflet. This technique has proven durable in the mid-term follow-up in our small series and warrants further validation in larger cohorts.
OBJECTIVE: Current techniques for mitral valve repair (MVR) in Barlow's disease require high level of surgical expertise due to a complex anatomy. A novel and simple standardized technique that particularly considers the pathological changes of the mitral valve in Barlow's disease has been developed. METHODS: Between 2009 and 2013, 22 patients underwent minimally invasive MVR for Barlow's disease and severe mitral regurgitation (MR). A simple, standardized technique was applied, including resection of P2 segment of posterior mitral leaflet (PML) with preservation of the shortest chordae, transfer of the preserved chordae to A2, and implantation of a semi-rigid open ring. In 2015, all patients were contacted for follow-up by transthoracic echocardiography (TTE) and interviewed for their clinical status. RESULTS: During follow-up (mean 2.8 ± 1.1 years; 100% complete), one patient died due to abdominal bleeding 4 months after the initial MVR and one patient with severe calcification of PML underwent valve replacement due to recurrence of MR. Among the remaining cohort (mean follow-up 3.0 ± 1.0 years), NYHA class I, II and III was present in 13, 6, and 1, respectively. TTE demonstrated MR grade 0, 1+, or 2+ in 40, 55, and 5%, respectively, with mean and maximum transvalvular gradients ranging at 1.9 ± 1.7 and 4.7 ± 3.3 mmHg, respectively. CONCLUSIONS: A simple and standardized technique facilitates the repair of MR in the presence of Barlow's, simultaneously addressing the height of PML and the position of the anterior leaflet. This technique has proven durable in the mid-term follow-up in our small series and warrants further validation in larger cohorts.
Authors: Robin Varghese; Shinobu Itagaki; Anelechi C Anyanwu; Paula Trigo; Gregory Fischer; David H Adams Journal: Eur J Cardiothorac Surg Date: 2013-05-08 Impact factor: 4.191
Authors: Rick A Nishimura; Catherine M Otto; Robert O Bonow; Blase A Carabello; John P Erwin; Robert A Guyton; Patrick T O'Gara; Carlos E Ruiz; Nikolaos J Skubas; Paul Sorajja; Thoralf M Sundt; James D Thomas; Jeffrey L Anderson; Jonathan L Halperin; Nancy M Albert; Biykem Bozkurt; Ralph G Brindis; Mark A Creager; Lesley H Curtis; David DeMets; Robert A Guyton; Judith S Hochman; Richard J Kovacs; E Magnus Ohman; Susan J Pressler; Frank W Sellke; Win-Kuang Shen; William G Stevenson; Clyde W Yancy Journal: J Thorac Cardiovasc Surg Date: 2014-05-09 Impact factor: 5.209
Authors: Michael A Borger; Anna F Kaeding; Joerg Seeburger; Serguei Melnitchouk; Michael Hoebartner; Michael Winkfein; Martin Misfeld; Friedrich W Mohr Journal: J Thorac Cardiovasc Surg Date: 2014-01-10 Impact factor: 5.209
Authors: Serguei I Melnitchouk; Joerg Seeburger; Anna F Kaeding; Martin Misfeld; Friedrich W Mohr; Michael A Borger Journal: Ann Cardiothorac Surg Date: 2013-11
Authors: Patrick Perier; Wolfgang Hohenberger; Fitsum Lakew; Gerhard Batz; Paul Urbanski; Michael Zacher; Anno Diegeler Journal: Ann Thorac Surg Date: 2008-09 Impact factor: 4.330